BSECompany Update6d ago
Procter & Gamble Health Ltd
Stock Exchange is informed about an update on Ease of doing Investment - Special Window for Transfer and Dematerialization.
Procter & Gamble Health Ltd has informed the stock exchange about an update on Ease of doing Investment - Special Window for Transfer and Dematerialization. SEBI has extended the timeline for re-lodging transfer requests for physical shares lodged prior to April 01, 2019, and rejected/returned/not attended to due to deficiency in documents/process.
BSECompany UpdateMgmt Change4 Sept 2026
Procter & Gamble Health Ltd
The shareholders at their AGM held on September 3, 2026 approved the re-appointment of Mr. S. Madhavan as Independent Director of the Company for a period of 5 years effective November 15, 2026.
Procter & Gamble Health Ltd has announced the re-appointment of Mr. S. Madhavan as Independent Director for a period of 5 years, effective November 15, 2026, following approval by shareholders at the 59th Annual General Meeting on September 3, 2026.
BSEAGM/EGMResults4 Sept 2026
Procter & Gamble Health Ltd
Scrutinizers Report and E-Voting results for the Annual General Meeting held on September 3, 2026.
Procter & Gamble Health Ltd has announced the results of its 59th Annual General Meeting (AGM), which was held on September 3, 2026. The meeting saw a total of 5 resolutions being passed, including the appointment of a new director, ratification of remuneration payable to the Cost Auditor, and confirmation of payment of interim dividend and declaration of Final Dividend for the Financial Year ended March 31, 2026.
BSEAGM/EGMResults3 Sept 2026
Procter & Gamble Health Ltd
Enclosed a summary of proceedings of the Annual General Meeting held today, viz., September 3, 2026.
Procter & Gamble Health Ltd held its 59th Annual General Meeting on September 3, 2026, through video conference. The meeting approved the audited balance sheet, statement of profit and loss, and auditors' reports. The company also declared interim and final dividends, appointed a new director, and ratified the remuneration of the cost auditor. The meeting concluded with the announcement of the voting results to be made available on the company's website within 2 working days.
BSEAGM/EGM12 Aug 2026
Procter & Gamble Health Ltd
The 59th Annual General Meeting of the Company is scheduled on Thursday, September 3, 2026 at 2:30 PM.
Procter & Gamble Health Ltd has announced the 59th Annual General Meeting (AGM) for the Financial Year ended March 31, 2026, scheduled on September 3, 2026, at 2:30 PM. The AGM notice and annual report have been sent to shareholders via email and are also available on the company's website.
BSEOthersESG12 Aug 2026
Procter & Gamble Health Ltd
The BRSR Report for the Financial Year ended March 31, 2026 is enclosed.
Procter & Gamble Health Ltd has released its Business Responsibility and Sustainability Report for the Financial Year ended March 31, 2026, which forms part of the Annual Report for the Financial Year ended March 31, 2026.
BSEOthersResults12 Aug 2026
Procter & Gamble Health Ltd
Annual Report for the Financial Year 2025-26 is enclosed for the Annual General Meeting scheduled on Thursday September 3, 2026.
Procter & Gamble Health Ltd has announced the release of its Annual Report for the Financial Year 2025-26, ahead of its 59th Annual General Meeting scheduled on September 3, 2026.
BSEAGM/EGMResults12 Aug 2026
Procter & Gamble Health Ltd
Enclosed herewith is the Annual Report for the Financial Year 2025-26 and Notice calling the 59th Annual General Meeting of the Company, scheduled on Thursday, September 3, 2026 at 2:30 p.m.
Procter & Gamble Health Ltd has announced its Annual Report for the Financial Year 2025-26 and Notice calling the 59th Annual General Meeting of the Company, scheduled on September 3, 2026. The report includes financial highlights, director's report, business responsibility & sustainability report, and corporate governance report. Shareholders can register to express their views or ask questions during the AGM by August 27, 2026.
BSECorp. ActionDividend10 Aug 2026
Procter & Gamble Health Ltd
Record Date for Purpose of Dividend
Procter & Gamble Health Ltd has announced the record date for the purpose of dividend and AGM, with the 59th AGM scheduled for September 3, 2026, and the record date set for August 27, 2026. The company also notified the payment of final dividend to eligible members by September 27, 2026.
BSECompany Update▲ PositiveResults6 Aug 2026
Procter & Gamble Health Ltd
Press Release on the Unaudited Financial Results for the Quarter ended June 30, 2026.
Procter & Gamble Health Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with sales up 7% and PAT up 45% compared to the same period last year.
BSEResult▲ PositiveResults6 Aug 2026
Procter & Gamble Health Ltd
Unaudited Financial Results for the Quarter ended June 30, 2026
Procter & Gamble Health Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit before tax of ₹12,912 lakhs, a 9.3% increase from the previous quarter's ₹11,811 lakhs. The company's total income was ₹37,459 lakhs, a 0.4% increase from the previous quarter's ₹37,045 lakhs. Expenses for the quarter were ₹27,027 lakhs, a 12.1% decrease from the previous quarter's ₹30,727 lakhs.
BSEBoard MeetingResults6 Aug 2026
Procter & Gamble Health Ltd
Outcome of Board Meeting.
Procter & Gamble Health Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹3,637.7 lakhs, total income at ₹36,759 lakhs, and profit before tax at ₹12,912 lakhs.